Viridian Therapeutics, Inc. (VRDN)
NCM – Real Time Price. Currency in USD
23.19
+0.22 (0.96%)
Market open: Aug 12, 2026, 10:39 AM EDT
22.98
+0.01 (0.04%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
23.19
+0.22 (0.96%)
Market open: Aug 12, 2026, 10:39 AM EDT
22.98
+0.01 (0.04%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $242.9M significantly exceeds cash reserves ($165.0M), raising financial stability concerns
Total current assets $1.1B exceed Total current liabilities $63.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-15.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$106.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 16.95 | 6.05 | 10 | |
| Quick ratio | 16.95 | 5.63 | 10 | |
| Debt to Equity | 0.37 | 0.30 | 7.0 | |
| Debt to Assets | 0.22 | 1.04 | 7.0 | |
| Interest coverage | -15.20 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 2M | 314K | 302K | 71M | 71M |
| Gross Profit | 1M | -1M | -938K | 70M | 70M |
| Operating Income | -134M | -254M | -299M | -363M | -405M |
| Net Income | -130M | -238M | -209M | -282M | -369M |
| EBITDA | -134M | -253M | -298M | -362M | -404M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -94.29 | -190.8 | 1.0 |
| Next quarter | 13620.72 | 10.45 | 8.5 |
| Current year | -69.42 | -18.42 | 1.0 |
| Next year | 968.59 | 34.08 | 10 |
| Weighted average score | 5.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 101.42 | -21.17 | -16.66 | 10.9 | 4.8 |
| Y/Y | 278.67 | -26.18 | -4.99 | -41.38 | 3.3 |
| 3y average | 7757.95 | -35.3 | 3.28 | -46.81 | 4.0 |
| 5y average | 4683.17 | -28.23 | 25.55 | -59.38 | 5.5 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |